LifeQuotes.com, the online life insurance price comparison service that offers instant quotes from 50 highly-rated life insurers, today released the results of a new life insurance market survey that ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

The latest analyst update for Pacific Biosciences of California cuts the rating to Underweight and trims the price target ...

Explore Virtus InfraCap US Preferred Stock ETF vs. First Trust Preferred Securities and Income ETF on yields, holdings, and ...

Since 2000, real U.S. GDP growth has expanded at the slowest 25-year growth rate in U.S. history, despite profound ...

In this interview, Ben Sommers, MD, PhD, a primary care physician and professor of healthcare economics at the Harvard T.H.

B.B. was such a total artist. He was such an entity. The singing, the playing, the songs. I think he made, like, sixty ...

The United States, which entered this war in expectation of a short, sharp win along the Venezuela model, is now preparing ...

Sanofi and Regeneron's Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results show ...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Rachel Reeves's statement in the House of Commons on Tuesday sought to reassure the House of Commons, the markets and the ...